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Dimerization dictates the message
The different members of the human type I interferon (IFN) family can induce distinct cellular responses, even though they all bind to the same cell surface receptor. All IFNs evoke a potent antiviral response, for example, but IFN␤ is far more effective than IFN␣2 at inhibiting cell proliferation. Such "functional plasticity" is a common feature of cytokine signaling, but the mechanisms by which different ligands use the same receptor to induce different responses remain unknown. Wilmes et al. now demonstrate that the effects of IFNs depend on their ability to promote receptor dimerization (1) .
The type I IFN receptor consists of two subunits, IFNAR1 and IFNAR2, which have low and high ligand binding affi nities, respectively. Different IFNs, in turn, have different affi nities for the receptor subunits, and IFN␤'s relatively high affi nity for IFNAR1 appears to be crucial for its specifi c functional effects (2) . Cytokine receptors are often thought to "preassemble" in the plasma membrane before they bind their ligands, but Jacob Piehler, from the University of Osnabrück in Germany, previously found that, at least in vitro, IFNs fi rst bind to the high-affi nity IFNAR2 subunit, and then recruit the low-affi nity IFNAR1 chain to form an active ternary complex (3). Moreover, due to its higher affi nity for IFNAR1, IFN␤ was better than IFN␣2 at inducing receptor dimerization (2) . "So it seemed like the recruitment of IFNAR1 might be critical for tuning the cellular response," Piehler explains. "But we needed to demonstrate this in cells." Piehler and colleagues, led by graduate student Stephan Wilmes, were also interested in how functional plasticity might be regulated by a protein called USP18, which, after being transcriptionally induced by IFN signaling, feeds back to inhibit the pathway (4, 5).
Wilmes et al. fi rst used single-molecule TIRF microscopy to monitor the binding of fl uorescently labeled IFN␣2 to the endogenous IFN receptor in vivo (1) . By comparing the behavior of IFN␣2 mutants with different affi nities for the two receptor subunits, the researchers concluded that IFNs do, in fact, recruit IFNAR1 into a ternary complex with IFNAR2, and that this process is inhibited by USP18. "Cells expressing USP18 lose the ability to bind IFN␣2 because receptor dimerization isn't as effi cient," Piehler says.
To confi rm this fi nding, Wilmes et al. directly visualized the assembly of individual receptors using fl uorescently labeled receptor subunits expressed at physiological levels. In the absence of IFNs, the subunits were not preassembled or even organized in close proximity to each other. In the presence of ligand, however, the researchers could observe individual IFNAR1 and IFNAR2 chains come together to form a ternary complex. "The subunits fl oat independently in the plasma membrane until the ligand is there, when they dimerize very effi ciently," Piehler explains.
As in the ligand-binding assays, dimerization efficiency depended on the ligand's affi nity for IFNAR1, and the process was inhibited by USP18. Previous reports have demonstrated that USP18 binds to the cytoplasmic tail of IFNAR2, potentially displacing the kinase Jak1 (4, 6). Wilmes et al. found that IFNAR2's Jak1-binding domain promoted dimerization, suggesting that the kinase somehow stabilizes the ternary ligand-receptor complex.
Thus, after its early induction by IFN signaling, USP18 might interfere with Jak1-mediated complex stabilization, thereby reducing the effi ciency of receptor dimerization so that ligands with a relatively low affi nity for IFNAR1, such as IFN␣2, can no longer recruit this subunit to form an active signaling complex. IFN␤, with its relatively high affi nity for IFNAR1, would still be able to induce receptor dimerization in the presence of USP18, allowing it to trigger additional cellular responses that require sustained IFN signaling.
The researchers now want to further investigate this mechanism of functional plasticity. "We want to pinpoint the role of Jak1 in receptor dimerization and to determine how USP18 interferes with the process," Piehler says.
